ATE163676T1 - MOLECULAR CLONES OF HIV-1 AND THEIR USE - Google Patents

MOLECULAR CLONES OF HIV-1 AND THEIR USE

Info

Publication number
ATE163676T1
ATE163676T1 AT91920794T AT91920794T ATE163676T1 AT E163676 T1 ATE163676 T1 AT E163676T1 AT 91920794 T AT91920794 T AT 91920794T AT 91920794 T AT91920794 T AT 91920794T AT E163676 T1 ATE163676 T1 AT E163676T1
Authority
AT
Austria
Prior art keywords
hiv
present
relates
dna segments
molecular clones
Prior art date
Application number
AT91920794T
Other languages
German (de)
Inventor
Marvin S Reitz Jr
Genoveffa Franchini
Phillip D Markham
Robert C Gallo
Franco C Lori
Mikulas Popovic
Suzanne Garnter
Original Assignee
Us Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24399839&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE163676(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Us Health filed Critical Us Health
Application granted granted Critical
Publication of ATE163676T1 publication Critical patent/ATE163676T1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/974—Aids related test

Abstract

The present invention relates to the HIV-1 strains MN-ST1 and BA-L which are typical United States HIV-1 isotypes. The present invention relates to DNA segments encoding the envelope protein of MN-ST1 or BA-L, to DNA constructs containing such DNA segments and to host cells transformed with such constructs. The viral isolates and envelope proteins of the present invention are of value for use in vaccines and bioassays for the detection of HIV-1 infection in biological samples, such as blood bank samples.
AT91920794T 1990-10-17 1991-10-17 MOLECULAR CLONES OF HIV-1 AND THEIR USE ATE163676T1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US59949190A 1990-10-17 1990-10-17

Publications (1)

Publication Number Publication Date
ATE163676T1 true ATE163676T1 (en) 1998-03-15

Family

ID=24399839

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91920794T ATE163676T1 (en) 1990-10-17 1991-10-17 MOLECULAR CLONES OF HIV-1 AND THEIR USE

Country Status (10)

Country Link
US (3) US5420030A (en)
EP (1) EP0554389B2 (en)
JP (1) JP2767078B2 (en)
AT (1) ATE163676T1 (en)
AU (1) AU649502B2 (en)
CA (1) CA2093427C (en)
DE (1) DE69129034T3 (en)
DK (1) DK0554389T4 (en)
ES (1) ES2115622T5 (en)
WO (1) WO1992006990A1 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341482C (en) * 1984-10-31 2005-05-10 Paul A. Luciw Process for preparing fragments of aids-associated retroviruses
DE4228787A1 (en) * 1992-08-29 1994-03-03 Chemotherapeutisches Forschungsinstitut Georg Speyer Haus New HIV-1 virus isolates of a subtype, vaccines against HIV-1 virus infections of this subtype and process for their preparation, use of the HIV-1 virus isolates
JP3277045B2 (en) * 1992-10-06 2002-04-22 デイド・ベーリング・マルブルク・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング HIV-group retroviruses and uses thereof
WO1994028929A1 (en) 1993-06-07 1994-12-22 Genentech, Inc. Hiv envelope polypeptides
ATE241385T1 (en) * 1993-08-11 2003-06-15 Wyeth Corp RECOMBINANT ADENOVIRUS VACCINES
DE4405810A1 (en) 1994-02-23 1995-08-24 Behringwerke Ag Peptides derived from a retrovirus from the HIV group and their use
US6585979B1 (en) 1996-07-08 2003-07-01 Genentech, Inc. HIV envelope polypeptides and immunogenic composition
FR2756843B1 (en) 1996-12-09 1999-01-22 Inst Nat Sante Rech Med NON-M NON-O HIV-1 STRAINS, FRAGMENTS AND APPLICATIONS
US6001558A (en) * 1997-06-25 1999-12-14 Ortho Clinical Diagnostics, Inc. Amplification and detection of HIV-1 and/or HIV 2
US6322976B1 (en) * 1998-05-28 2001-11-27 Medical Research Council Compositions and methods of disease diagnosis and therapy
US6908612B2 (en) 1999-10-08 2005-06-21 University Of Maryland Biotechnology Institute Virus coat protein/receptor chimeras and methods of use
US7311920B1 (en) 1999-10-08 2007-12-25 University Of Maryland Biotechnology Institute Virus coat protein/receptor chimeras and methods of use
EP2020450B9 (en) 2000-09-01 2011-09-14 Gen-Probe Incorporated Amplification of HIV-1 sequences for detection of sequences associated with drug-resistance mutations
US6582920B2 (en) 2000-09-01 2003-06-24 Gen-Probe Incorporated Amplification of HIV-1 RT sequences for detection of sequences associated with drug-resistance mutations
US20080057492A1 (en) * 2002-05-10 2008-03-06 Quinnan Jr Gerald V Interacting site for gp41 on gp120 of hiv-1
CA2505583C (en) * 2002-12-03 2014-07-15 University Of Massachusetts Polyvalent, primary hiv-1 glycoprotein dna vaccines and vaccination methods
JP4038679B2 (en) * 2003-05-13 2008-01-30 住友電気工業株式会社 Fixing jig for semiconductor laser bar
WO2005016952A2 (en) * 2003-05-19 2005-02-24 Duke University Polyvalent immunogen
US8617816B2 (en) * 2007-03-16 2013-12-31 454 Life Sciences, A Roche Company System and method for detection of HIV drug resistant variants

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6226300A (en) * 1984-10-10 1987-02-04 セントコ−・インコ−ポレ−テツド Cloning and developping of htlv-iii dna
US5820865A (en) * 1988-01-26 1998-10-13 The United States Of America As Represented By The Department Of Health And Human Services Method to induce cytotoxic T Lymphocytes specific for a broad array of HIV-1 isolates using hybrid synthetic peptides
IL89567A0 (en) * 1988-03-28 1989-09-10 Univ Leland Stanford Junior Mutated hiv envelope protein
EP0406557B1 (en) * 1989-05-25 2001-10-17 Novartis AG Multivalent repressor of gene function
WO1991019011A1 (en) * 1990-06-08 1991-12-12 Repligen Corporation Immunoassays for anti-hiv-1 antibodies

Also Published As

Publication number Publication date
CA2093427A1 (en) 1992-04-18
DK0554389T3 (en) 1998-12-07
US5420030A (en) 1995-05-30
ES2115622T5 (en) 2003-03-16
JPH05507205A (en) 1993-10-21
DE69129034D1 (en) 1998-04-09
AU649502B2 (en) 1994-05-26
EP0554389B2 (en) 2002-08-14
US5576000A (en) 1996-11-19
DK0554389T4 (en) 2002-11-11
EP0554389A4 (en) 1994-07-06
WO1992006990A1 (en) 1992-04-30
DE69129034T3 (en) 2003-05-08
US5869313A (en) 1999-02-09
EP0554389B1 (en) 1998-03-04
JP2767078B2 (en) 1998-06-18
EP0554389A1 (en) 1993-08-11
CA2093427C (en) 2008-01-15
AU8936391A (en) 1992-05-20
ES2115622T3 (en) 1998-07-01
DE69129034T2 (en) 1998-10-08

Similar Documents

Publication Publication Date Title
ATE163676T1 (en) MOLECULAR CLONES OF HIV-1 AND THEIR USE
Bryan Vinblastine and microtubules: II. Characterization of two protein subunits from the isolated crystals
BR7908410A (en) MEDIA FOR DETECTION OF HBV ANTIBODIES IN BLOOD SERUM, AND PROCESS FOR DETECTION OF THE PRESENCE OF HEPATITIS B VIRUS INFECTION IN HUMAN BEINGS
Wagner et al. Structural proteins of vesicular stomatitis viruses
BR9711457A (en) Compounds and process for the treatment and diagnosis of mycobacterial infections.
ATE294864T1 (en) OUTER MEMBRANE PROTEIN OF HAEMOPHILUS
ATE90384T1 (en) RECOMBINANT VIRUS PROTEINS ACCOMPANYING LYMPHADENOPATHIC SYNDROME AND/OR ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS).
ATE110782T1 (en) RECOMBINANT HUMAN ENDOTHELIAL CELL GROWTH FACTOR.
EE200200709A (en) Use of a Composition Containing a Fusion Protein and Nucleic Acid Encoding a Fusion Protein and a Fusion Polypeptide
DE69737125D1 (en) STREPTOCOCCUS PNEUMONIAE ANTIGENES AND VACCINES
SE8703225L (en) MONOCLONAL ANTIBODIES AND PEPTIDES USEFUL IN TREATMENT AND DIAGNOSTIZATION OF HIV INFECTIONS
FI861485A0 (en) PRODUCERING AV IMMUNOLOGISKT REAKTIVA VIRALA PROTEINER.
ATE122394T1 (en) PANCREATIC ISLE CELL ANTIGENS OBTAINED BY MOLECULAR CLONING.
FR2660757B1 (en) METHOD OF IDENTIFYING OR DETERMINING PROTEINS AND APPLICATIONS.
DE59508137D1 (en) SPECIFIC BINDING SUBSTANCES FOR ANTIBODIES AND THEIR USE FOR IMMUNOASSAYS OR VACCINE
DK0491713T3 (en) Rubella E1 peptides and C peptides
DE69934953D1 (en) Vaccines against coccidiosis
FI885025A0 (en) KOAGULATIONSHAEMMANDE PROTEIN PP4-X, DESS FRAMSTAELLNING OCH ANVAENDNING.
Gazitt et al. Early and late changes in the glycoproteins of Friend erythroleukemia cells induced to differentiate
Yakobson et al. Monkey interferon: activity on human cells and chromatographic properties
ATE380882T1 (en) VECTOR SYSTEM FOR SCREENING ACTIVE INGREDIENTS
KR950000879A (en) Novel Human Immunodeficiency Virus-2 (HIV-2)
Righthand et al. Characterization of a Cellular Protein that Promotes SV40 Infection in Human Cells
Reitz et al. Molecular clones of HIV-1 viral strains MN-ST1 and BA-L and uses thereof
KR950025098A (en) Purification of Human Erythropoietin Factor Expressed in Recombinant Insect Cells

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0554389

Country of ref document: EP

EELA Cancelled due to lapse of time